toxic epidermal necrolysis

A single case of toxic epidermal necrolysis was reported in 1968.

The mortality for toxic epidermal necrolysis is 30-40 percent.

Toxic epidermal necrolysis has occurred from the use of tetrazepam including at least one reported death.

Toxic epidermal necrolysis is a rare and usually severe adverse reaction to certain drugs.

Ofloxacin, and Trovan have also been associated with toxic epidermal necrolysis.

The most severe of the three is toxic epidermal necrolysis (TEN).

Ciprofloxacin-induced toxic epidermal necrolysis was first reported in 1991 with numerous other cases in the following years.

Toxic epidermal necrolysis has been reported.

Its use was discontinued in many countries in 1996, due to rare but serious cases of toxic epidermal necrolysis.

Reported side-effects include injection site reactions, rash, and rarely toxic epidermal necrolysis.

Stevens-Johnson syndrome or toxic epidermal necrolysis usually occurs during the first few months of treatment with carbamazepine.

(1986) Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids.

This problem is called toxic epidermal necrolysis, and it can be deadly if it is not treated.

She developed toxic epidermal necrolysis, as well as endocarditis and gastrointestinal hemorrhage.

A very rare and serious type of generalized red rash is toxic epidermal necrolysis (TEN).

He survived toxic epidermal necrolysis and a skin loss of over 75% of his body with multi-system organ failure as a result.

Stevens-Johnson syndrome and toxic epidermal necrolysis are diseases where there is a breakdown of the dermoepidermal junction.

Nikolsky's sign is almost always present in toxic epidermal necrolysis and is associated with pemphigus vulgaris.

Stevens-Johnson syndrome (toxic epidermal necrolysis) can occur when mebendazole is combined with high doses of metronidazole.

Toxic epidermal necrolysis (Lyell's syndrome) may also be encountered and may be life-threatening.

Primidone also causes exfoliative dermatitis, Stevens-Johnson syndrome, and toxic epidermal necrolysis.

SSSS may be difficult to distinguish from toxic epidermal necrolysis and pustular psoriasis.

Cholestasis, Stevens-Johnson syndrome, and toxic epidermal necrolysis are some other rare side-effects that may occur.

Severe or life-threatening skin reactions have been observed in 1.5% of patients, including Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity.

However, SSSS must be differentiated carefully from toxic epidermal necrolysis, which carries a poor prognosis.